AB.PA
AB Science SA
Price:  
1.23 
EUR
Volume:  
108,661.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-179.8%
Upside

As of 2025-09-18, the EV/EBITDA ratio of AB Science SA (AB.PA) is -14.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 88.92 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -5.98 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.2x - 7.4x 7.1x
Forward P/E multiples 10.1x - 10.6x 10.3x
Fair Price (1.11) - (0.86) (0.98)
Upside -190.4% - -170.1% -179.8%
1.23 EUR
Stock Price
(0.98) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-16 -15.03
2025-09-15 -14.98
2025-09-12 -14.71
2025-09-11 -14.98
2025-09-10 -14.81
2025-09-09 -14.62
2025-09-08 -14.49
2025-09-05 -14.51
2025-09-04 -14.71
2025-09-03 -14.88
2025-09-02 -14.66
2025-09-01 -16.16
2025-08-29 -14.51
2025-08-28 -14.60
2025-08-27 -14.75
2025-08-26 -14.56
2025-08-25 -15.20
2025-08-22 -15.52
2025-08-21 -15.58
2025-08-20 -15.50
2025-08-19 -15.84
2025-08-18 -16.03
2025-08-15 -16.11
2025-08-14 -15.52
2025-08-13 -15.84
2025-08-12 -16.16
2025-08-11 -15.94
2025-08-08 -16.01
2025-08-07 -15.88
2025-08-06 -15.47
2025-08-05 -15.86
2025-08-04 -16.31
2025-08-01 -16.99
2025-07-31 -17.54
2025-07-30 -17.63
2025-07-29 -17.71
2025-07-28 -18.93
2025-07-25 -16.56
2025-07-24 -15.64
2025-07-23 -15.03
2025-07-22 -14.56
2025-07-21 -14.79
2025-07-18 -15.00
2025-07-17 -14.88
2025-07-16 -15.47
2025-07-15 -15.77
2025-07-14 -15.94
2025-07-11 -16.35
2025-07-10 -16.60
2025-07-09 -16.52